ES2061380A1 - Empleo del factor de crecimiento fibroblastico y sus derivados como neuroprotectores y neuromoduladores. - Google Patents

Empleo del factor de crecimiento fibroblastico y sus derivados como neuroprotectores y neuromoduladores.

Info

Publication number
ES2061380A1
ES2061380A1 ES09202360A ES9202360A ES2061380A1 ES 2061380 A1 ES2061380 A1 ES 2061380A1 ES 09202360 A ES09202360 A ES 09202360A ES 9202360 A ES9202360 A ES 9202360A ES 2061380 A1 ES2061380 A1 ES 2061380A1
Authority
ES
Spain
Prior art keywords
fibroblast growth
neuroprotective
growth factors
ischaemia
growth factor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09202360A
Other languages
English (en)
Other versions
ES2061380B1 (es
Inventor
Gallego Guillermo Gimenez
Sanchez Pedro Cuevas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GUILLERMO GIMENEZ GALLEGO (TITULAR AL 50%)
Original Assignee
Boehringer Ingelheim Espana SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Espana SA filed Critical Boehringer Ingelheim Espana SA
Priority to ES09202360A priority Critical patent/ES2061380B1/es
Priority to CA002127537A priority patent/CA2127537A1/en
Priority to PCT/EP1993/003234 priority patent/WO1994012201A1/en
Priority to JP6512718A priority patent/JPH07504205A/ja
Priority to EP94901818A priority patent/EP0624094A1/en
Publication of ES2061380A1 publication Critical patent/ES2061380A1/es
Application granted granted Critical
Publication of ES2061380B1 publication Critical patent/ES2061380B1/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • A61K38/1825Fibroblast growth factor [FGF]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

EMPLEO DEL FACTOR DE CRECIMIENTO FIBROBLASTICO Y SUS DERIVADOS COMO NEUROPROTECTORES Y NEUROMODULADORES FRENTE AL DAÑO PRODUCIDO POR LA ISQUEMIA Y LA REPERFUSION CEREBRAL, ASI COMO FRENTE A LA ACTIVIDAD MOTORA Y A TODOS LOS COMPUESTOS RELACIONADOS CON LA MISMA, EN AQUELLAS SITUACIONES CLINICAS QUE REQUIERAN UNA PROTECCION NEURONAL TRAS LA ISQUEMIA CEREBRAL O CAROTIDEA. IGUALMENTE, SE JUSTIFICA EL USO FARMACOLOGICO DEL FACTOR DE CRECIMIENTO DE LOS FIBROBLASTOS ACIDOS Y BASICOS, Y DE TODOS LOS COMPUESTOS RELACIONADOS CON LOS MISMOS, EN LAS SITUACIONES CLINICAS QUE REQUIERAN UNA DISMINUCION DE LA AGITACION Y DE LA AGRESIVIDAD.
ES09202360A 1992-11-23 1992-11-23 Empleo del factor de crecimiento fibroblastico y sus derivados como neuroprotectores y neuromoduladores. Expired - Lifetime ES2061380B1 (es)

Priority Applications (5)

Application Number Priority Date Filing Date Title
ES09202360A ES2061380B1 (es) 1992-11-23 1992-11-23 Empleo del factor de crecimiento fibroblastico y sus derivados como neuroprotectores y neuromoduladores.
CA002127537A CA2127537A1 (en) 1992-11-23 1993-11-19 Use of fibroblast growth factors as neuroprotective and neuromodulatory agents
PCT/EP1993/003234 WO1994012201A1 (en) 1992-11-23 1993-11-19 Use of fibroblast growth factors as neuroprotective and neuromodulatory agents
JP6512718A JPH07504205A (ja) 1992-11-23 1993-11-19 神経保護及び神経調節の薬剤としての繊維芽細胞増殖因子の使用
EP94901818A EP0624094A1 (en) 1992-11-23 1993-11-19 Use of fibroblast growth factors as neuroprotective and neuromodulatory agents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES09202360A ES2061380B1 (es) 1992-11-23 1992-11-23 Empleo del factor de crecimiento fibroblastico y sus derivados como neuroprotectores y neuromoduladores.

Publications (2)

Publication Number Publication Date
ES2061380A1 true ES2061380A1 (es) 1994-12-01
ES2061380B1 ES2061380B1 (es) 1995-07-01

Family

ID=8278876

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09202360A Expired - Lifetime ES2061380B1 (es) 1992-11-23 1992-11-23 Empleo del factor de crecimiento fibroblastico y sus derivados como neuroprotectores y neuromoduladores.

Country Status (5)

Country Link
EP (1) EP0624094A1 (es)
JP (1) JPH07504205A (es)
CA (1) CA2127537A1 (es)
ES (1) ES2061380B1 (es)
WO (1) WO1994012201A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5831117A (en) 1995-01-20 1998-11-03 G. D. Searle & Co. Method of preparing retroviral protease inhibitor intermediates
DE69634907T2 (de) * 1995-04-25 2006-05-18 Ajinomoto Co., Inc. Fibroblastenwachstumsfragmente
ES2201287T5 (es) * 1996-03-22 2007-10-16 Curis, Inc. Metodo para mejorar la recuperacion funcional de la coordinacion motora, del habla o la percepcion sensorial tras una isquemia o trauma del sistema nervioso central.
AU749530B2 (en) * 1997-06-11 2002-06-27 Acorda Therapeutics, Inc. CNS neuroregenerative compositions and methods of use
AU8855798A (en) * 1997-07-03 1999-01-25 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Novel composition for treating, preventing and/or delaying ischemic cell death
JP3507884B2 (ja) * 2000-03-07 2004-03-15 新潟大学長 遺伝子発現を指標とする統合失調症の客観的診断法
CA2571243A1 (en) 2004-06-21 2006-01-05 The Board Of Trustees Of The Leland Stanford Junior University Genes and pathways differentially expressed in bipolar disorder and/or major depressive disorder
EP1951908B1 (en) 2005-11-12 2013-08-07 The Board of Trustees of The Leland Stanford Junior University Fgf2-related methods for diagnosing and treating depression

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0357240A2 (en) * 1988-08-03 1990-03-07 Ethicon, Inc. EGF for preventing tissue damage after ischemia
EP0388226A2 (en) * 1989-03-16 1990-09-19 Ajinomoto Co., Inc. Means for the treatment of senile dementia, memory disorders and related conditions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993008828A1 (en) * 1991-11-08 1993-05-13 Syntex-Synergen Neuroscience Joint Venture Methods for the treatment of neuronal damage associated with ischemia, hypoxia or neurodegeneration

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0357240A2 (en) * 1988-08-03 1990-03-07 Ethicon, Inc. EGF for preventing tissue damage after ischemia
EP0388226A2 (en) * 1989-03-16 1990-09-19 Ajinomoto Co., Inc. Means for the treatment of senile dementia, memory disorders and related conditions

Also Published As

Publication number Publication date
EP0624094A1 (en) 1994-11-17
JPH07504205A (ja) 1995-05-11
ES2061380B1 (es) 1995-07-01
CA2127537A1 (en) 1994-06-09
WO1994012201A1 (en) 1994-06-09

Similar Documents

Publication Publication Date Title
ES2061380A1 (es) Empleo del factor de crecimiento fibroblastico y sus derivados como neuroprotectores y neuromoduladores.
IT8422619V0 (it) Brandina o lettino a struttura deformabile per cabine di veicoli industriali e simili, particolarmente adatta per ridurre i danni al conducente in caso di incidenti stradali.
SG49654A1 (en) The use of hyaluronic acid to repair ischemia reperfusion damage
ITTO910332A1 (it) Organo di adduzione del carburante per autoveicoli
ATE320356T1 (de) Schutztür für fahrerkabinen, insbesondere von nutzfahrzeugen
DE69302571D1 (de) Frontkraftheber für traktor oder dergleichen
MY109602A (en) Heteroatoms-containing tricyclic compounds
GB1133674A (en) Improvements relating to motor vehicles
GB9207624D0 (en) Improvements relating to the protection of corrosion-susceptible members
USD354604S (en) Forklift
ES2011264B3 (es) Cuerpo de vehiculo provisto de guardabarros adaptado a proteger las ruedas.
DK0621926T3 (da) Styreliste til en beskyttelseshætte til træfræsemaskiner
USD346076S (en) Bunk bed
GB961121A (en) Improvements relating to motor vehicles
USD299775S (en) Lifting bed accessory for the repair of vehicle bodies
GB1464534A (es)
USD291681S (en) Automobile valance panel
ITMI920951A0 (it) Dispositivo di sollevamento applicato posteriormente ad un veicolo peril trasporto dotato di sbarra antiincastro.
USD295166S (en) Automobile front bumper
USD295165S (en) Automobile front bumper
USD291678S (en) Automobile front bumper
IT8953366V0 (it) Pedana per l accesso alla cabina diguida di un veicolo industriale
MX9503283A (es) Montaje de protector contra choques de borde y rueda para maleta rodante.
ITAL910012V0 (it) Impugantura per chiavi, in particolare di veicoli, applicabile in modoamovibile al corpo di chiavi qualsivoglia
GB969568A (en) Improvements in or relating to protective cushions, intended primarily for luggage racks in vehicles

Legal Events

Date Code Title Description
PC2A Transfer of patent

Owner name: GUILLERMO GIMENEZ GALLEGO (TITULAR AL 50%)